Pancreatic Cancer Research

ResearcherErasmus MCActive in the last 2 years

Maikel Petrus Peppelenbosch

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9112-6028; OpenAlex author ID A5069908102. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 3 papers · 2021: 1 paper · 2022: 4 papers · 2023: 1 paper · 2024: 1 paper

Papers 13

  1. Calix[6]arene dismantles extracellular vesicle biogenesis and metalloproteinases that support pancreatic cancer hallmarks. Co-author DOI 10.1016/j.cellsig.2024.111174↗
  2. Mutation Analysis of Pancreatic Juice and Plasma for the Detection of Pancreatic Cancer. Co-author DOI 10.3390/ijms241713116↗
  3. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2022.04.010↗
  4. Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of pancreatic cancer. Co-author DOI 10.1016/j.pan.2022.06.260↗
  5. Three Distinct Stroma Types in Human Pancreatic Cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen-Letter. Co-author DOI 10.1158/1078-0432.ccr-21-2257↗
  6. Size and Concentration of Extracellular Vesicles in Pancreatic Juice From Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.14309/ctg.0000000000000465↗
  7. Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival. Co-author DOI 10.3389/fmed.2021.751110↗
  8. Upregulated β-catenin signaling does not affect survival of pancreatic cancer cells during dual inhibition of GSK3B and HDAC. Co-author DOI 10.1016/j.pan.2019.12.019↗
  9. Optimization of Pancreatic Juice Collection: A First Step Toward Biomarker Discovery and Early Detection of Pancreatic Cancer. Co-author DOI 10.14309/ajg.0000000000000939↗
  10. CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcino… Co-author DOI 10.3390/cancers12092546↗
  11. mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma. Co-author DOI 10.1016/j.canlet.2014.01.014↗
  12. Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies. Co-author DOI 10.1016/j.ctrv.2013.11.005↗
  13. Pancreatic cancer: promise for personalised medicine? Last author DOI 10.1016/j.canlet.2011.11.034↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gwenny Manel Fuhler · 9 shared papers, 2020–2024 · strength 1.45
  2. Marco J. Bruno · 11 shared papers, 2012–2023 · strength 1.37
  3. Iris J. M. Levink · 7 shared papers, 2020–2023 · strength 1.09
  4. Djuna L. Cahen · 6 shared papers, 2020–2023 · strength 0.94
  5. Kateryna Nesteruk · 4 shared papers, 2020–2022 · strength 0.59
  6. Isis J. Visser · 2 shared papers, 2022 · strength 0.35
  7. Helon Guimarães Cordeiro · 1 shared paper, 2024 · strength 0.22
  8. Carmen Veríssima Ferreira‐Halder · 1 shared paper, 2024 · strength 0.22
  9. Karin Juliane Pelizzaro‐Rocha · 1 shared paper, 2024 · strength 0.22
  10. Rachid Bouzid · 1 shared paper, 2022 · strength 0.15
  11. Jerome F. Cros · 1 shared paper, 2022 · strength 0.15
  12. Michail Doukas · 1 shared paper, 2022 · strength 0.15
  13. Henri Braat · 3 shared papers, 2012–2014 · strength 0.14
  14. Steven W.M. Olde Damink · 1 shared paper, 2021 · strength 0.13
  15. Merel R. Aberle · 1 shared paper, 2021 · strength 0.13
  16. Sander S. Rensen · 1 shared paper, 2021 · strength 0.13
  17. Lodewijk A.A. Brosens · 1 shared paper, 2021 · strength 0.13
  18. Lydi M.J.W. van Driel · 1 shared paper, 2020 · strength 0.10
  19. Casper H.J. van Eijck · 2 shared papers, 2014 · strength 0.09
  20. Leonie Hartl · 1 shared paper, 2020 · strength 0.09
  21. Mark P.G. Dings · 1 shared paper, 2020 · strength 0.09
  22. C. Arnold Spek · 1 shared paper, 2020 · strength 0.09
  23. Frederike Dijk · 1 shared paper, 2020 · strength 0.09
  24. JanWillem Duitman · 1 shared paper, 2020 · strength 0.09
  25. Marc G. Besselink · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.